Join
Live feed
·
INSIDERFilingvia Quantisnow
X4 Pharmaceuticals Inc. logo

Chief Operating Officer Dibiase Mary sold $38,329 worth of shares (67,695 units at $0.57) and was granted 230,645 shares, increasing direct ownership by 56% to 452,060 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XFOR (X4 Pharmaceuticals Inc.) and more on Quantisnow.